Moreover, when samples were divided into six subgroups according to the tumor type, BL patients showed a significantly higher expression of both YY1 and BIRC5, if compared with less aggressive B-NHLs (including FL, MCL and MZL). Here, BIRC5 is linked to marginal zone lymphoma.